Cite

HARVARD Citation

    Pather, S. et al. (2018). Re: Neoadjuvant chemotherapy for advanced ovarian cancer. Who really benefits?. Australian and New Zealand journal of obstetrics and gynaecology. pp. E25-E26. [Online]. 
  
Back to record